Compare · CVS vs GRDN
CVS vs GRDN
Side-by-side comparison of CVS Health Corporation (CVS) and Guardian Pharmacy Services Inc. (GRDN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVS and GRDN operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- CVS is the larger of the two at $118.41B, about 47.1x GRDN ($2.51B).
- GRDN has been more active in the news (17 items in the past 4 weeks vs 9 for CVS).
- CVS has more recent analyst coverage (25 ratings vs 6 for GRDN).
- Company
- CVS Health Corporation
- Guardian Pharmacy Services Inc.
- Price
- $92.39-0.19%
- $39.47-0.48%
- Market cap
- $118.41B
- $2.51B
- 1M return
- +2.33%
- -
- 1Y return
- +11.95%
- -
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 9
- 17
- Recent ratings
- 25
- 6
CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Latest CVS
- CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
- MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards
- Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
- CVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area
- CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
- CVS Health to hold third quarter 2026 earnings conference call
- Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
- CVS Health declares quarterly dividend
- As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide
- Aetna expands bundled oncology prior authorizations, easing provider burden and accelerating member access to care
Latest GRDN
- Officer Mudd William Franklin converted options into 38,282 shares, increasing direct ownership by 39% to 136,747 units (SEC Form 4)
- Officer Weir Robert converted options into 23,450 shares, increasing direct ownership by 29% to 103,333 units (SEC Form 4)
- Member of 10% Owner Group Ackerman John converted options into 1,884,996 shares (SEC Form 4)
- Member of 10% Owner Group Salentine Thomas J Jr converted options into 6,100,175 shares (SEC Form 4)
- Member of 10% Owner Group Burke Fred converted options into 1,298,825 shares, increasing direct ownership by 61% to 3,438,064 units (SEC Form 4)
- Member of 10% Owner Group Pharmacy Investors, Llc converted options into 1,413,939 shares, increasing direct ownership by 58% to 3,863,806 units (SEC Form 4)
- Officer Martin David Norman converted options into 39,865 shares, increasing direct ownership by 39% to 140,905 units (SEC Form 4)
- Officer Tuch Jeffrey converted options into 55,578 shares, increasing direct ownership by 32% to 231,847 units (SEC Form 4)
- Member of 10% Owner Group Forbes Kendall converted options into 608,570 shares, increasing direct ownership by 58% to 1,651,059 units (SEC Form 4)
- Member of 10% Owner Group Bindley William E converted options into 6,100,175 shares (SEC Form 4)